Common mistakes with IGF-1 LR3

Avoid the most common pitfalls when working with IGF-1 LR3 in a research setting: storage, reconstitution, concentration, and COA verification mistakes.

Mistake 1: Improper storage after reconstitution

Once IGF-1 LR3 is reconstituted with bacteriostatic water, it must be stored at 2-8°C (refrigerated) and used within 28 days. A common mistake is leaving the vial at room temperature for extended periods, which degrades the peptide and can invalidate experimental results.

Freeze-thaw cycles are another issue — each cycle reduces peptide integrity. If your protocol requires long-term storage, keep the lyophilised vial frozen at -20°C until the moment of reconstitution.

Mistake 2: Concentration miscalculation

Calculating the target concentration wrong is one of the most common experimental errors with IGF-1 LR3. Always double-check:

  • The stated vial mass (e.g. 5mg, 10mg)
  • The volume of bacteriostatic water added
  • The resulting concentration (mass / volume)
  • The volume of reconstituted solution you draw into the syringe for each dose point

A simple spreadsheet or lab notebook with these values at the top of every experiment can prevent costly errors.

Mistake 3: Skipping COA verification

Researchers sometimes trust a supplier's purity claim without checking the actual COA. For IGF-1 LR3, always:

  1. Match the batch number on your vial to the COA on the product page
  2. Verify the HPLC chromatogram shows a single clean peak
  3. Confirm the mass spectrometry reading matches the theoretical molecular weight
  4. Check the expiry date

Skipping this step means you are treating purity as a marketing claim rather than a verifiable fact. Peptify publishes every batch COA at peptifyuk.com, downloadable directly from each product page.

Buy IGF-1 LR3 for research

99%+ HPLC-verified IGF-1 LR3 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.

Frequently asked questions

What is IGF-1 LR3?

IGF-1 LR3 is a modified version of IGF-1 with a 13-amino acid extension that prevents binding to IGF-binding proteins, resulting in enhanced bioactivity and a longer half-life.

What is IGF-1 LR3 researched for?

Published preclinical research has examined IGF-1 LR3 in cell-proliferation, myocyte-pathway, and PI3K/Akt signalling studies. The extended half-life makes it useful in protocols requiring sustained in-vitro receptor engagement.

What purity does Peptify supply?

Peptify IGF-1 LR3 is 99%+ HPLC-verified, with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.